Improving outcomes for children with leukaemia internationally: the results of scientifically designed clinical trials and translational research

Impact: Health impacts, Societal impacts


Researchers at the University of Manchester (UoM) have made a significant impact nationally and internationally on improving the outcome for children with acute lymphoblastic leukaemia (ALL) (~450 pa in the UK). The changes in clinical practice based on our research are now national standards of care for children with de novo and relapsed ALL in the UK and Ireland. Other international groups have adopted key findings from the results of our frontline trials. Our relapse protocol for childhood ALL underpins European and North American strategy for the management of relapsed disease.

Category of impact

  • Health impacts
  • Societal impacts
2014 - 2019

Related information